临床肿瘤学杂志

• 综述与讲座 • 上一篇    下一篇

miR-100与肿瘤关系的研究进展

于万涛1,王朝霞2   

  1. 1 南京医科大学第一临床医学院临床医学系 2 南京医科大学第二附属医院肿瘤科
  • 收稿日期:2013-08-15 修回日期:2013-09-17 出版日期:2014-08-31 发布日期:2014-08-31
  • 通讯作者: 王朝霞

Research progress on miR-100 and tumor

YU Wantao, WANG Zhaoxia.   

  1. Department of Clinical Medicine, the First Clinical Medical College, Nanjing Medical University
  • Received:2013-08-15 Revised:2013-09-17 Online:2014-08-31 Published:2014-08-31
  • Contact: WANG Zhaoxia

摘要: miR-100既可表现出致癌基因的作用,又可表现出抑癌基因的作用,其不仅在多种肿瘤(宫颈癌、前列腺癌、膀胱癌和肺癌等)的发生、发展中发挥重要作用,而且还可增加肿瘤细胞对化疗药物的敏感性。miR-100有望成为肿瘤治疗的新靶点及预测预后的新分子标记。本文结合国内外最新报道对miR-100与肿瘤相关性的研究进展作一综述。

Abstract: Recent studies have shown that miR-100 can act as oncogene or tumor suppressor gene in different tumors. It not only plays an important role in the development and progression of a variety of tumor types(cervical cancer, prostate cancer, bladder cancer, lung cancer, etc), but also can resensitize tumor cell towards chemotherapeutic drugs. miR-100 is expected to become a new target for cancer treatment and a new molecular marker for prognostic predictors. In this review, we summarize the latest progresses, both domestic and overseas, in the roles of miR-100 in the tumor development.

No related articles found!
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!